摘要
目的探讨妈咪爱联合蒙脱石散早期预防新生儿黄疸的疗效及安全性。方法回顾性分析2010年1月—2012年12月该院出生120例新生儿的临床资料。结果治疗前,两组新生儿的血清胆红素水平比较,差异无统计学意义(P>0.05);治疗后,观察组新生儿的血清胆红素水平升高幅度明显小于对照组,经统计学分析,差异有统计学意义(P<0.05)。观察组新生儿的黄疸发生率、血清胆红素峰浓度和黄疸持续时间均明显低于对照组,经统计学分析,差异有统计学意义(P<0.05),治疗期间未发生明显的不良反应。结论妈咪爱联合蒙脱石散早期预防新生儿黄疸的疗效确切,无不良反应,值得临床推广应用。
Objective To explore the clinical effect and safety of mommy loves combined with montmorillonite powder early prevention of neonatal jaundice. Methods Retrospectively analyzed clinical data of 120 cases of neonatal in 2010 January to 2012 December in our hospital was born. Results Before treatment, compare the serum bilirubin level in neonates in the two groups, no significant difference, P0.05; after treatment, serum bilirubin level in neonates in the observation group increased significantly than those in the control group, the statistical analysis, P0.05, the difference was statistically significant. The observation group neonatal serum bilirubin concentration and the duration of jaundice was significantly lower than that of the control group, the statistical analysis, P0.05, the difference was statistically significant, significant adverse reaction did not occur during treatment. Conclusion The curative effect of mommy love combined with montmorillonite powder early prevention of neonatal jaundice is exact, without adverse reaction, it is worthy of clinical application.
出处
《中外医疗》
2013年第12期15-16,共2页
China & Foreign Medical Treatment
关键词
妈咪爱
蒙脱石散
新生儿黄疸
Medilac-vita
Montmorillonite
Newborn Huang Dan
